Alexander A Fitzpatrick's Net Worth
$914 Thousand
Who is Alexander A Fitzpatrick?
Alexander A Fitzpatrick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KINTERA INC, Evofem Biosciences, Inc., ARS Pharmaceuticals, Inc., and VERENIUM CORP.
SEC CIK
Alexander A Fitzpatrick's CIK is 0001398595
Past Insider Trading and Trends
2018 was Alexander A Fitzpatrick's most active year for acquiring shares with 7 total transactions. Alexander A Fitzpatrick's most active month to acquire stocks was the month of January. 2008 was Alexander A Fitzpatrick's most active year for disposing of shares, totalling 10 transactions. Alexander A Fitzpatrick's most active month to dispose stocks was the month of June. 2023 saw Alexander A Fitzpatrick paying a total of $319,954.01 for 786,258 shares, this is the most they've acquired in one year. In 2020 Alexander A Fitzpatrick cashed out on 78,879 shares for a total of $342,485.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KINTERA INC No price found
SVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.96K |
—
|
—
|
0
|
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evofem Biosciences, Inc. (EVFM) Snapshot price: $0.0314
General Counsel and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +138.62% | 300K |
—
|
—
| 516.42K |
Feb 18
| |||
Form 4
| -35.67% | -120.00K |
—
|
—
| 216.42K |
Dec 31
| |||
Form 4
| +8.03% | 25K |
$0.39 | $9,725.00 | 336.42K |
Dec 20
| |||
Form 4
| +3.32% | 10K |
$1.03 | $10,250.00 | 311.42K |
Jun 10
| |||
Form 4
| -12.26% | -42.12K |
$0.86 | -$36,223.20 | 301.42K |
May 20
| |||
Form 4
| +139.33% | 200K |
—
|
—
| 343.54K |
Feb 3
| |||
Form 4
| +6.76% | 9.09K |
$2.20 | $19,998.00 | 143.54K |
Nov 17
| |||
Form 4
| -19.03% | -31.59K |
$3.31 | -$104,562.90 | 134.45K |
Jun 5
| |||
Form 4
| -19.21% | -39.49K |
$4.99 | -$197,040.13 | 166.04K |
May 22
| |||
Form 4
| -3.66% | -7.80K |
$5.24 | -$40,882.48 | 205.53K |
May 6
| |||
Form 4
| +236.85% | 150K |
—
|
—
| 213.33K |
Feb 5
| |||
Form 4
| -10.90% | -7.75K |
$6.22 | -$48,186.34 | 63.33K |
Nov 25
| |||
Form 4
| -9.83% | -7.75K |
$5.74 | -$44,467.78 | 71.08K |
Nov 20
| |||
Form 4
| -18.95% | -18.43K |
$5.01 | -$92,319.27 | 78.83K |
Oct 16
| |||
Form 4
| -1.32% | -1.30K |
$5.13 | -$6,648.48 | 97.25K |
Aug 22
| |||
Form 4
| -7.31% | -7.78K |
$6.36 | -$49,461.72 | 98.55K |
Jun 10
| |||
Form 4
| -1.21% | -1.30K |
$3.55 | -$4,607.90 | 106.33K |
Apr 1
| |||
Form 4
| +86.77% | 50K |
—
|
—
| 107.62K |
Feb 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
| -23.17% | -17.38K |
$3.78 | -$65,685.06 | 57.62K |
Oct 16
| |||
Form 4
| +7.14% | 5K |
$2.21 | $11,035.00 | 75K |
Aug 20 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
∞
| 70K |
—
|
—
| 70K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $6.31
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +2,905.29% | 86.26K |
$3.71 | $319,954.01 | 89.23K |
Sep 28 - Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERENIUM CORP No price found
Sr. VP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.50K |
$4.00 | -$29,984.00 |
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
∞
| 7.5K |
$1.90 | $14,227.75 | 7.5K |
Aug 18 - Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||